DrugDashboards

Azacitidine

Azacitidine · AZACITIDINE 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous; Subcutaneous · NorthStar RxLLC

NDC 16714-0927-01 · 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON · ANDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.4010per billing unit (1 MG)HCPCS J9025 · Jul 1, 2026
  • Part D plans paid (avg)$185.60per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$270.47
Reported to Texas DSHS · 2026 annual filing · Northstar Rx Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.401
HCPCS J9025 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$19,336
513 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $1,839.38 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA201537
TE code
AP
Approval date
Sep 16, 2013
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Azacitidine, Injection, 100 mg (NDC 68001-313-56)Dec 22, 2020
    Other
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)Dec 22, 2020
    Demand increase for the drug
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg (NDC 16729-306-10)Dec 21, 2020
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg (NDC 43598-305-62)Dec 18, 2020
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg (NDC 72485-201-01)Dec 18, 2020
    Other
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)Dec 18, 2020
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)Dec 18, 2020
    Discontinuation of the manufacture of the drug
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)Dec 18, 2020
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Vidaza, Injection, 100 mg (NDC 59572-102-01)Dec 18, 2020
    month 69 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Azacitidine (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesAZACITIDINE 100 mg/1Jul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
BluePoint Laboratories.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Celgene CorporationAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Civica, Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Eugia US LLCAZACITIDINE 100 mg/4mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCAZACITIDINE 100 mg/30mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.AZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Msn Laboratories Private LimitedAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Panacea Biotec LimitedAZACITIDINE 100 mg/50mLJul 15, 2026Sep 2, 2026
Reliance Life Sciences Private LimitedAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics LLCAZACITIDINE 100 mg/1Jul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.AZACITIDINE 100 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Azacitidine — NDC 16714-0927-01," retrieved September 3, 2026, https://drugdashboards.com/drug/16714092701.

Free to cite with attribution — see how the data is put together.